FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort

A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma†

(2013) A. C. Roy et al.   ANNALS OF ONCOLOGY

Clinicopathological characteristics and optimal management for esophagogastric junctional cancer; a single center retrospective cohort study

(2013) Hiroaki Ito et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Current questions for the treatment of advanced gastric cancer

(2012) A. Cervantes et al.   CANCER TREATMENT REVIEWS

Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone

(2012) Jung Hun Kang et al.   JOURNAL OF CLINICAL ONCOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Clinicopathological characteristics and treatment strategies in early gastric cancer: a retrospective cohort study

(2011) Hiroaki Ito et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Comparison of Gastric Cancer Survival Following R0 Resection in the United States and Korea Using an Internationally Validated Nomogram

(2010) Vivian E. Strong et al.   ANNALS OF SURGERY

Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial

(2010) Jaffer A. Ajani et al.   JOURNAL OF CLINICAL ONCOLOGY

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma

(2009) Luigi Di Lauro et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis

(2009) Tetsuya Ueda et al.   LANCET ONCOLOGY

Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

(2008) Salah-Eddin Al-Batran et al.   JOURNAL OF CLINICAL ONCOLOGY

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

(2008) Wasaburo Koizumi et al.   LANCET ONCOLOGY